Subtopic Deep Dive
Opioid Use Disorder Screening Instruments
Research Guide
What is Opioid Use Disorder Screening Instruments?
Opioid Use Disorder Screening Instruments are validated assessment tools such as the Opioid Risk Tool (ORT) and Drug Abuse Screening Test (DAST) used to identify individuals at risk for opioid misuse or abuse in clinical settings.
These instruments predict risk factors like prior substance use and mental health disorders to enable early intervention (Sehgal, 2012; 322 citations). Tools like RIOSORD assess overdose risk in specific populations such as veterans (Zedler et al., 2015; 139 citations). Over 10 papers in the provided list review predictors and monitoring techniques for opioid adherence.
Why It Matters
Screening instruments like those in RIOSORD enable targeted interventions, reducing overdose risk in high-risk groups such as veterans (Zedler et al., 2015). In primary care, low adoption of risk tools contributes to unchecked chronic opioid misuse, highlighting the need for better integration (Starrels et al., 2011). Validated predictors from Sehgal (2012) guide safer prescribing in chronic pain patients, lowering societal costs from abuse.
Key Research Challenges
Low Adoption of Risk Tools
Primary care providers underuse screening strategies even for high-risk chronic pain patients (Starrels et al., 2011; 123 citations). This gap persists despite available predictors, leading to increased misuse. Implementation barriers limit preventive impact.
UDT Interpretation Deficits
Physicians show poor knowledge in interpreting urine drug tests for opioid adherence monitoring (Reisfield et al., 2007; 79 citations). Misinterpretation affects risk assessment accuracy. Targeted education is needed for reliable use.
Population-Specific Validation
Risk indices like RIOSORD perform well in veterans but require validation across diverse groups (Zedler et al., 2015; 139 citations). Cancer pain patients face unique misuse risks not fully addressed by general tools (Anghelescu et al., 2013). Adaptation challenges persist.
Essential Papers
Prescription Opioid Abuse in Chronic Pain:A Review of Opioid Abuse Predictors andStrategies to Curb Opioid Abuse
Nalini Sehgal · 2012 · Pain Physician · 322 citations
Both chronic pain and prescription opioid abuse are prevalent and continue to exact a heavy toll on patients, physicians, and society. Individuals with chronic pain and co-occurring substance use d...
Clinical Policy: Critical Issues in the Prescribing of Opioids for Adult Patients in the Emergency Department
Stephen V. Cantrill, Michael D. Brown, Russell J. Carlisle et al. · 2012 · Annals of Emergency Medicine · 241 citations
Development of a Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in Veterans' Health Administration Patients
Barbara Zedler, Lin Xie, Li Wang et al. · 2015 · Pain Medicine · 139 citations
RIOSORD performed well in identifying medical users of prescription opioids within the Veterans' Health Administration at elevated risk of overdose or life-threatening respiratory depression, those...
Low Use of Opioid Risk Reduction Strategies in Primary Care Even for High Risk Patients with Chronic Pain
Joanna L. Starrels, William C. Becker, Mark G. Weiner et al. · 2011 · Journal of General Internal Medicine · 123 citations
Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders
Paxton Bach, Daniel M. Hartung · 2019 · Addiction Science & Clinical Practice · 107 citations
Monitoring Opioid Adherence in ChronicPain Patients: Tools, Techniques, and Utility
Laxmaiah Manchikanti · 2008 · Pain Physician · 99 citations
Opioids are important, if not essential, agents in treating certain types of chronic pain. However, the prevalence of drug misuse, abuse, and addiction has fostered considerable consternation among...
Opioid Misuse and Abuse: Risk Assessment and Management in Patients with Cancer Pain
Doralina L. Anghelescu, Jennifer Harman Ehrentraut, Lane Faughnan · 2013 · Journal of the National Comprehensive Cancer Network · 82 citations
The FDA's 2012 risk evaluation and mitigation strategy is a major step toward systematically reducing the inherent risks of chronic opioid therapy for pain, but does not distinguish between risks r...
Reading Guide
Foundational Papers
Start with Sehgal (2012; 322 citations) for core predictors of opioid abuse; follow with Manchikanti (2008; 99 citations) on monitoring tools including UDT; then Starrels et al. (2011; 123 citations) for adoption challenges.
Recent Advances
Zedler et al. (2015; 139 citations) on RIOSORD development; Bach & Hartung (2019; 107 citations) on pharmacist roles in screening; Greene & Chambers (2015; 72 citations) critiquing pseudoaddiction.
Core Methods
Risk indices via multivariate models (Zedler et al., 2015); self-report tools like ORT scoring prior history; UDT for adherence with immunoassay/GC-MS confirmation (Reisfield et al., 2007; Manchikanti, 2008).
How PapersFlow Helps You Research Opioid Use Disorder Screening Instruments
Discover & Search
Research Agent uses searchPapers and citationGraph on 'Opioid Risk Tool validation' to map 322-citation Sehgal (2012) as a hub connected to Starrels et al. (2011) and Zedler et al. (2015), then exaSearch uncovers 50+ related screening papers; findSimilarPapers expands to tools like DAST.
Analyze & Verify
Analysis Agent applies readPaperContent to Zedler et al. (2015) RIOSORD validation, verifies risk index performance via runPythonAnalysis on reported AUC metrics with GRADE grading for evidence strength, and uses verifyResponse (CoVe) for statistical claims on overdose prediction.
Synthesize & Write
Synthesis Agent detects gaps in primary care adoption from Starrels et al. (2011) vs. pharmacy roles (Bach & Hartung, 2019), flags contradictions in pseudoaddiction (Greene & Chambers, 2015); Writing Agent uses latexEditText, latexSyncCitations for a review paper, and latexCompile for submission-ready output.
Use Cases
"Extract and plot RIOSORD risk scores from Zedler 2015 across veteran subgroups"
Research Agent → searchPapers('RIOSORD Zedler') → Analysis Agent → readPaperContent → runPythonAnalysis(pandas/matplotlib on table data) → matplotlib plot of AUC by demographics.
"Draft a systematic review on opioid screening tools with citations"
Synthesis Agent → gap detection on 20 papers → Writing Agent → latexEditText(structured sections) → latexSyncCitations(Sehgal 2012 et al.) → latexCompile(PDF review with tables).
"Find GitHub repos implementing ORT or DAST calculators from papers"
Research Agent → citationGraph(Sehgal 2012) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect(pulls validated scoring code for local testing).
Automated Workflows
Deep Research workflow conducts systematic review of 50+ papers on screening tools: searchPapers → citationGraph → DeepScan(7-step verification with CoVe checkpoints on RIOSORD metrics). Theorizer generates hypotheses on integrating UDT with ORT from Manchikanti (2008) and Reisfield (2007). DeepScan analyzes adoption gaps in Starrels et al. (2011) with runPythonAnalysis on low-use statistics.
Frequently Asked Questions
What defines Opioid Use Disorder Screening Instruments?
Validated tools like Opioid Risk Tool (ORT) and RIOSORD index identify misuse risk via predictors such as prior substance use and mental health history (Sehgal, 2012).
What methods are used in these screening instruments?
Risk indices combine demographic, psychiatric, and substance use factors; RIOSORD uses logistic regression for overdose prediction in veterans (Zedler et al., 2015). Urine drug testing supports monitoring but requires accurate interpretation (Reisfield et al., 2007).
What are key papers on this topic?
Sehgal (2012; 322 citations) reviews predictors; Zedler et al. (2015; 139 citations) develops RIOSORD; Starrels et al. (2011; 123 citations) shows low risk tool use.
What open problems exist?
Low adoption in primary care (Starrels et al., 2011), physician deficits in UDT interpretation (Reisfield et al., 2007), and need for broader population validation beyond veterans (Zedler et al., 2015).
Research Opioid Use Disorder Treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Opioid Use Disorder Screening Instruments with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Opioid Use Disorder Treatment Research Guide